Africa (WHO region) vs Niger: Meningococcal A conjugate (MENGA) vaccine immunization coverage (%)
Africa (WHO region)
27.0%
in 2025
Niger
82.0%
in 2025
Africa (WHO region) rank
5th
Niger rank
3rd
Meningococcal A conjugate (MENGA) vaccine immunization coverage (%) over time
- Africa (WHO region)
- Niger
How they compare
Niger currently reports 82.0% against 27.0% in Africa (WHO region), a difference of 55.0%.
That makes Niger's figure about 3.0 times Africa (WHO region)'s.
Across all 10 years both countries report, Niger has been ahead every year.
Africa (WHO region) ranks 5th and Niger ranks 3rd of 7 groups.
Niger has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Africa (WHO region) | Niger | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 8.8% | 43.8% | 35.0% | Niger |
| 2020s | 25.7% | 81.7% | 56.0% | Niger |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher meningococcal a conjugate (menga) vaccine immunization coverage (%), Africa (WHO region) or Niger?
- Niger, at 82.0% against 27.0% in Africa (WHO region) as of 2025.
- What is the difference in meningococcal a conjugate (menga) vaccine immunization coverage (%) between Africa (WHO region) and Niger?
- 55.0%, with Niger ahead.
- How many years of comparable data are there for Africa (WHO region) and Niger?
- 10 years are reported by both, from 2016 to 2025.
- How do Africa (WHO region) and Niger rank globally for meningococcal a conjugate (menga) vaccine immunization coverage (%)?
- Africa (WHO region) ranks 5th and Niger ranks 3rd of 7 groups.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Meningococcal A conjugate (MENGA) vaccine immunization coverage (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.